2026 Southeastern Residency Conference

Background/Purpose: Asymptomatic bacteriuria (ASB) is defined as the isolation of quantifiable bacteria in the urine in the absence of urinary symptoms. Per 2019 IDSA guidelines for the management of asymptomatic bacteriuria, healthy nonpregnant women, patients with diabetes, and older adult women should not be screened or treated for asymptomatic bacteriuria. Despite most recent guideline recommendations, estimated incidence of inappropriate asymptomatic bacteriuria treatment range from 40-83% in the United States. Similarly, 2021 CDC guidelines recommend treating bacterial vaginosis in symptomatic women. Currently there is no data supporting the routine screening of bacterial vaginosis in healthy, nonpregnant women. This quality improvement initiative aims to evaluate the impact of provider education and order set optimization on the quality of symptom documentation for uncomplicated urinary tract infections and bacterial vaginosis in women's health clinics at the Fayetteville NC VA Coastal Health Care System (FNCVACHCS).
Methodology: This project will identify Veterans treated for uUTI and/or BV at FNCVACHCS during two periods: September 1–November 28, 2025 (pre-intervention) and a subsequent 2.5-month post-intervention period. Data collection will utilize Computerized Patient Record System (CPRS) and Microsoft Excel software to review women’s health providers’ notes, cultures, and labs. The primary objective assessed the difference in symptom documentation rates after intervention. The secondary outcome evaluated treatment of uUTI and BV 28 days before and after intervention implementation. Primary and secondary endpoint changes will be compared to assess the impact of provider education and order set adjustments.
Results: In progress
Conclusion: In progress